Patent applications published 1 December 2010
Selected patent applications from the weekly European Patents Bulletin
- Aryl-hydroxyethylamino-pyrimidines and triazines as modulators of fatty acid amine hydrolase
Janssen Pharmaceutica 2254415*
- Stabilised malathion microcapsule formulations
Ceminova 2254419*
- CNS pharmaceutical compsns and methods of use
Targia Pharmaceuticals 2254420*
- Paraoxonase 1 enzymatic activity, a risk preductor for major adverse cardiovascular events
The Cleveland Clinic Foundation 2254470*
- Processes of making oral compsns containing gel networks
Procter & Gamble 2254548*
- Aqueous pharmaceutical compsns containing borate-polyol complexes
Alcon Research 2254549*
- Pharmaceutical compsn with gelling properties containing a tyrosine derivative
Ethypharm; Universite de Montreal 2254550*
- Sterilised sucralfate gel
Pierre Farbe Dermo-Cosmétique 2254551*
- Long-term stable pharmaceutical preparation having the active ingredient glycerol trinitrate
G Pohl-Boskamp 2254552*
- Abuse resistant melt extruded formulation having reduced alcohol interaction
Abbott 2254553*
- Sugar glassified virus like particles (VLPs)
Novavax 2254554*
- Solubility-enhanced forms of aprepitant and pharmaceutical compsns thereof
Dr Reddy's Laboratories Ltd; Dr Reddy’s Laboratories Inc 2254555*
- Orally-disintegrating solid preparation
Takeda Pharmaceutical 2254556*
- Methods to inhibit tumour cell growth by using proton pump inhibitors
Bio-Quant 2254557*
- Orally disintegrating tablets with speckled appearance
Alpex Pharma 2254558*
- Compsn for sustained release delivery of proteins or peptides
QPS 2254559*
- Preparation of nanoparticles by using a vibrating nozzle device
LEK Pharmaceuticals 2252560*
- Abuse deterrent transdermal formulations of opiate agonists and agonist-antagonists
AllTranz 2254561*
- Nanosuspension with antifungal medication to be administered via inhalation with improved impurity profile and safety
Schlichthaar, Rainer 2254562*
- Pharmaceutical combinations comprising specified age breaker and further drugs, I.A. antihypertensive drugs, antidiabetic drugs etc
Torrent Pharmaceuticals 2254563*
- Combinations comprising 3-phenylsulphonyl-8-piperazinyl-1yl-quinoline
Glaxo Group 2254564*
- New use for cannabinoids
GW Pharma 2254565*
- Kinase protein binding inhibitors
University of Florida Research Foundation 2254566*
- Novel use of zinc N-acetyltaurinate
Tri-Inov 2254567*
- Methods and assays for detecting and treating hypoglycaemia
University of Miami 2254568*
- Protopanaxadiol-type ginsenoside compsns and uses thereof
Raptor Therapeutics 2254569*
- Combination comprising paclitaxel for treating ovarian cancer
Actelion Pharmaceuticals 2254570*
- Combinations of an anti-HER2 antibody-drug conjugate and chemotherapeutic agents, and methods of use
Genentech 2254571*
- Compounds that enhance ATOH-1 expression
Massachusetts Eye and Ear Infirmary 2254572*
- Compsns comprising phytoestrogens selective for estrogen beta receptor and dietary fibres
CM&D Pharma 2254573*
- Beta-lactones as antibacterial agents
Ludwig-Maximilians-Universität München 2254574*
- Medicament
The University of Manchester 2254575*
- Androgen receptor-ablative agents
The Ohio State University Research Foundation 2254576*
- AMPA receptor antagonists for epilepsy, mental disorders or deficits in sensory organ
Eisai R&D Management 2254577*
- Combination of a carbostyril and carnitine
Otsuka Pharmaceutical 2254578*
- Use of compounds binding to the sigma receptor ligands for the treatment of neuropathic pain developing as a sequence of chemotherapy
Laboratoires del Dr Esteve 2254579*
- Methods for treating disorders using NMDA NR2B-subtype selective antagonist
Evotec Neurosciences 2254580*
- Pteridine derivatives for treating respiratory disease
TargeGen 2254581*
- Methods of treating viral infections
Chimerix 2254582*
- Anticancer agent
Rheinische Friedrich-Wilhelms Universität 2254583*
- Biocompatible injectable products with zinc and/or zinc-form saccharide-salt release, and uses thereof
Keysan Consulting 2254584*
- Chronic wound treatment
Technostics 2254585*
- Mesenchymal stem cell particles
Agency for Science, Technology and Research, Singapore 2254586*